Publications

5674 Results

A randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good risk germ cell tumors: A multi-institutional study.

Authors
DF Bajorin;MF Sarosdy;DG Pfister;M Mazumdar;RJ Motzer;HI Scher;NL Geller;WR Fair;H Herr;P Sogani;J Sheinfeld;P Russo;V Vlamis;R Carey;NJ Vogelzang;ED Crawford;GJ Bosi
Journal / Conference
JCO 11(4):598-606
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8789

Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma: A Southwest Oncology Group study.

Authors
ME Marshall;MK Wolf;ED Crawford;S Taylor;B Blumenstein;R Flanigan;FJ Meyers;HE Hynes;B Barlogie;M Eisenberger
Journal / Conference
IND 11:207-209
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8802

Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma: A Southwest Oncology Group study.

Authors
WS Fletcher;DS Daniels;VK Sondak;B Dana;R Townsend;HE Hynes;LF Hutchins;JR Pancoast
Journal / Conference
AJCO 16(4):359-362
Year
1993
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8804

Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.

Authors
MM Zalupski;J Benedetti;SP Balcerzak;LF Hutchins;RJ Belt;A Hantel;JW Goodwin
Journal / Conference
IND 11:337-341
Year
1993
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8930

Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group trial.

Authors
SA Taylor;J Benedetti;D Schuller;SP Richman;GO Broun;A Hantel
Journal / Conference
IND 11:227-229
Year
1993
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8932

A phase II trial of piroxantrone in adenocarcinoma of the pancreas: A Southwest Oncology Group study.

Authors
TR Jenkins;C Tangen;JS Macdonald;G Weiss;R Chapman;A Hantel
Journal / Conference
IND 11:329-331
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8933

A phase II study of external beam radiation and chemotherapy with cisplatin/BCNU followed by BCNU alone of the treatment of incompletely resected high grade brain tumors: Preliminary results of a Southwest Oncology Group (SWOG) study (SWOG-9016).

Authors
S Petersdorf;C Upchurch;H Eyre;J Townsend;B Griffin;R Livingston;A Spence;M Berger
Journal / Conference
ASCO 12:176(#501)
Year
1993
Research Committee(s)
Brain
Study Number(s)
SWOG-9016

In the era of prostate specific antigen (PSA), is prostate acid phosphatase (PAP) necessary for staging prostate cancer? A Southwest Oncology Group study.

Authors
IM Thompson;EJ Zeidman;ED Crawford;AI Sagalowski;PF Schellhammer;RW deVere White;HB Grossman;E Klein;BA Lowe;AJ Bueschen;PT Scardino;RC Flanigan
Journal / Conference
American Urological Association Inc. 149:308A(#360)
Year
1993

Treatment of diffuse large-cell lymphoma: A summary of outcome for patients treated by the Southwest Oncology Group.

Authors
TP Miller;S Dahlberg
Journal / Conference
Malignant Lymphomas Including Hodgkins Disease 4:53-63
Year
1993
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14

Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer.

Authors
EV Hannigan;S Green;DS Alberts;R O'Toole;E Surwit
Journal / Conference
Oncology 50(Suppl.2):2-9
Year
1993
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412